PhaseBio Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
PHASQ
CUSIP
717224109
All holders as of
Q4 2022
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2022 Q4 5 558 k $15.6 k
2022 Q3 39 22.1 M $3.89 M
2022 Q2 50 23.4 M $14.0 M
2022 Q1 58 29.4 M $38.9 M
2021 Q4 58 28.4 M $74.2 M
2021 Q3 64 30.8 M $95.8 M
2021 Q2 57 30.4 M $113 M
2021 Q1 65 31.8 M $110 M
2020 Q4 63 15.8 M $53.1 M
2020 Q3 53 17.1 M $60.1 M
2020 Q2 64 18.3 M $84.3 M
2020 Q1 52 18.5 M $61.1 M
2019 Q4 53 19.6 M $120 M
2019 Q3 60 18.5 M $77.3 M
2019 Q2 53 18.8 M $245 M
2019 Q1 20 6.92 M $65.8 M
2018 Q4 16 6.87 M $21.2 M